Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines
Expert Review of Vaccines, 09/02/09
Kataoka K et al. – The strategy of a DNA–based mucosal adjuvant facilitates the targeting of mucosal dendritic cells, and thus is an effective and safe approach. It would also provide great flexibility for the development of effective vaccines for various mucosal pathogens.
Related Articles
Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses
Journal of Pharmacy and Pharmacology, 11/18/09
Relevance Score: 65%
The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women
Journal of Reproductive Immunology, 11/06/09
Relevance Score: 65%
A Monoclonal IgG Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin
Infection and Immunity, 10/29/09
Relevance Score: 65%
Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission
Journal of Investigative Dermatology, 10/19/09
Relevance Score: 65%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 49%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
Scandinavian Journal of Immunology, 12/16/09
Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine
Journal of Virology, 12/16/09
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009—10 influenza season: a multicentre, randomised controlled trial
The Lancet - Early Online Publication, 12/15/09
Article Search
Sponsor


See Latest Articles


